Frontiers | DPP4 in Diabetes
Dr.med. Jutta Karl - Fachärztin für Allgemeinmedizin - Medikamentöse Therapie des Diabetes mellitus vom Typ II mit Inkretinen
Frontiers | DPP4 in Diabetes
Synthesis and SAR of azolopyrimidines as potent and selective dipeptidyl peptidase-4 (DPP4) inhibitors for type 2 diabetes - ScienceDirect
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes | Scientific Reports
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications | Diabetology & Metabolic Syndrome | Full Text
Frontiers | Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect
Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway | Cell Death Discovery
Neuer DDP-4-Inhibitor Linagliptin
Pharmaceuticals | Free Full-Text | A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes
![dpp-4_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b "dpp-4_inhibitors [TUSOM | Pharmwiki]")
dpp-4_inhibitors [TUSOM | Pharmwiki]
KLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes - ScienceDirect
DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy - ScienceDirect
Effect of dual inhibition of DPP4 and SGLT2 on tacrolimus‐induced diabetes mellitus and nephrotoxicity in a rat model - Ko - 2022 - American Journal of Transplantation - Wiley Online Library
DPP4 in Cardiometabolic Disease | Circulation Research
Dipeptidyl peptidase-4 inhibitor - Wikipedia
Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition - ScienceDirect
Behandlung von Patienten ohne Risiko - diabetes-news : diabetes-news
Glucagon.com
PDB-101: Global Health: Diabetes Mellitus: Drugs: DPP4 inhibitor: DPP4
Ausgabe 1/2017: Update Diabetes mellitus
Discovery of Actions, so far Unknown, of DPP-4 Inhibitors, a Drug for Diabetes | Kanazawa University
